ONCTERNAL THERAPEUTICS INC's ticker is ONCT and the CUSIP is 68236P107. A total of 62 filers reported holding ONCTERNAL THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $94 | -5.1% | 313,300 | +9.2% | 0.00% | – |
| Q2 2023 | $99 | -50.5% | 287,000 | +12.5% | 0.00% | – |
| Q1 2023 | $200 | -17.4% | 255,100 | +5.5% | 0.00% | – |
| Q4 2022 | $242 | -100.0% | 241,800 | -75.3% | 0.00% | -100.0% |
| Q3 2022 | $874,000 | +22.2% | 979,800 | +52.2% | 0.00% | 0.0% |
| Q2 2022 | $715,000 | -5.4% | 643,734 | +18.4% | 0.00% | 0.0% |
| Q1 2022 | $756,000 | -11.6% | 543,800 | +44.4% | 0.00% | 0.0% |
| Q4 2021 | $855,000 | +43.7% | 376,532 | +163.7% | 0.00% | 0.0% |
| Q3 2021 | $595,000 | +139.9% | 142,805 | +173.6% | 0.00% | – |
| Q2 2021 | $248,000 | -48.7% | 52,200 | -47.0% | 0.00% | -100.0% |
| Q4 2020 | $483,000 | +92.4% | 98,569 | -33.3% | 0.00% | – |
| Q3 2020 | $251,000 | +30.1% | 147,683 | +117.0% | 0.00% | – |
| Q2 2020 | $193,000 | +141.2% | 68,048 | +149.1% | 0.00% | – |
| Q1 2020 | $80,000 | -3.6% | 27,317 | +30.2% | 0.00% | – |
| Q4 2019 | $83,000 | – | 20,982 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 360,000 | $1,710,000 | 0.88% |
| APIS CAPITAL ADVISORS, LLC | 120,000 | $570,000 | 0.49% |
| Parkman Healthcare Partners LLC | 415,384 | $1,973,000 | 0.43% |
| Altium Capital Management LP | 172,218 | $818,000 | 0.19% |
| Vigilare Wealth Management | 52,535 | $250,000 | 0.15% |
| BRIGHTON JONES LLC | 332,875 | $1,581,000 | 0.08% |
| Ikarian Capital, LLC | 200,204 | $950,000 | 0.08% |
| IPG Investment Advisors LLC | 31,106 | $147,754,000 | 0.04% |
| DOWLING & YAHNKE LLC | 150,464 | $715,000 | 0.04% |
| Jump Financial, LLC | 58,225 | $276,000 | 0.03% |